We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$182B
AUM Growth
-$8.9B
Cap. Flow
-$1.05B
Cap. Flow %
-0.58%
Top 10 Hldgs %
39.59%
Holding
518
New
26
Increased
181
Reduced
122
Closed
19

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$3.07B
2
YMM icon
Full Truck Alliance
YMM
+$1.57B
3
RMD icon
ResMed
RMD
+$715M
4
NVDA icon
NVIDIA
NVDA
+$647M
5
BABA icon
Alibaba
BABA
+$597M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.6%
2 Healthcare 23.23%
3 Technology 20.07%
4 Communication Services 12.81%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIAV icon
376
Viavi Solutions
VIAV
$9.66B
$20K ﹤0.01%
1,142
XPEL icon
377
XPEL
XPEL
$1.38B
$20K ﹤0.01%
295
AYX
378
DELISTED
Alteryx Inc
AYX
$20K ﹤0.01%
336
SGEN
379
DELISTED
Seagen Inc. Common Stock
SGEN
$20K ﹤0.01%
128
SRNE
380
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$20K ﹤0.01%
4,314
ACMR icon
381
ACM Research
ACMR
$5.79B
$19K ﹤0.01%
660
BLK icon
382
Blackrock
BLK
$176B
$19K ﹤0.01%
21
CELH icon
383
Celsius Holdings
CELH
$7.03B
$19K ﹤0.01%
780
INSM icon
384
Insmed
INSM
$28.6B
$19K ﹤0.01%
707
NKTR icon
385
Nektar Therapeutics
NKTR
$2.58B
$19K ﹤0.01%
92
NVAX icon
386
Novavax
NVAX
$1.31B
$19K ﹤0.01%
+130
New +$22.3K
NVEE
387
DELISTED
NV5 Global
NVEE
$19K ﹤0.01%
552
RMBS icon
388
Rambus
RMBS
$11B
$19K ﹤0.01%
630
-69
-10% -$1.75K
ROL icon
389
Rollins
ROL
$18.2B
$19K ﹤0.01%
562
SAIL
390
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$19K ﹤0.01%
388
CHD icon
391
Church & Dwight Co
CHD
$24.5B
$18K ﹤0.01%
179
GNTX icon
392
Gentex
GNTX
$5.07B
$18K ﹤0.01%
516
HUBB icon
393
Hubbell
HUBB
$27.2B
$18K ﹤0.01%
87
LOW icon
394
Lowe's Companies
LOW
$125B
$18K ﹤0.01%
69
NTNX icon
395
Nutanix
NTNX
$16.9B
$18K ﹤0.01%
563
ZNGA
396
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$18K ﹤0.01%
2,863
EBS icon
397
Emergent Biosolutions
EBS
$248M
$17K ﹤0.01%
385
EXPD icon
398
Expeditors International
EXPD
$23.2B
$17K ﹤0.01%
126
PD icon
399
PagerDuty
PD
$902M
$17K ﹤0.01%
503
-64
-11% -$2.48K
QDEL icon
400
QuidelOrtho
QDEL
$838M
$17K ﹤0.01%
128

Similar funds

Baillie Gifford & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Baillie Gifford & Co held 518 positions worth $182B, down 4.7% from $191B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q4 2021 filing shows 26 new, 181 increased, 122 reduced and 19 closed positions. Its largest new stake was Charles Schwab: 7,506,268 shares worth $631M. The largest sale was Tesla, an estimated $3.07B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q4 2021 buy was Charles Schwab: 7,506,268 shares worth $631M.
  • Baillie Gifford & Co added most to Moderna in Q4 2021, an estimated $1.04B increase.
  • Baillie Gifford & Co's biggest Q4 2021 reduction was Tesla, cutting an estimated $3.07B.
  • Baillie Gifford & Co fully exited Autohome in Q4 2021, selling an estimated $140M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $182B portfolio in Q4 2021.
  • Baillie Gifford & Co opened 26 new positions and closed 19 in Q4 2021.
  • Baillie Gifford & Co's portfolio value fell 4.7% quarter-over-quarter to $182B.

Based on Baillie Gifford & Co's 13F filing for Q4 2021, filed 20 Jan 2022.